{ "items": [ "\n\n
\n \n 9 June 2023\n \n
\n\n \n \n \n\n \n \n \nEight academics from the University of Oxford have joined the Royal Society as Fellows, including the Vice-Chancellor Professor Irene Tracey.
\n \n\n\n \n 9 June 2023\n \n
\n\n \n \n \n\n \n \n \nA new population-based study of 22 million people shows that autoimmune disorders now affect about one in ten individuals. The work, published in The Lancet, also highlights important socioeconomic, seasonal, and regional differences for several autoimmune disorders and provides new clues on possible causes behind these diseases.
\n \n\n\n \n 9 June 2023\n \n
\n\n \n \n \n\n \n \n \nAccording to some estimates, there is more than a one in four chance in the next decade of another global pandemic. We don\u2019t know whether this will be influenza, a coronavirus (like SARS and COVID), or something completely new. The World Health Organisation refers to this unknown future threat as 'Disease X'.
\n \n\n\n \n 9 June 2023\n \n
\n\n \n \n \n\n \n \n \nThe University of Oxford has partnered with other institutions and investors to agree terms which will greatly increase the UK\u2019s capacity to turn world-leading research into spinouts that will generate economic growth and societal impact.
\n \n\n\n \n 9 June 2023\n \n
\n\n \n \n \n\n \n \n \nA new study led by the University of Oxford has shown that overuse of antimicrobials in livestock production can drive the evolution of bacteria more resistant to the first line of the human immune response. The results, published today in the journal eLife, indicate that farmed pigs and chickens could harbour large reservoirs of cross-resistant bacteria, capable of fuelling future epidemics.
\n \n\n\n \n 17 April 2023\n \n
\n\n \n \n \n\n \n \n \nResearchers from the University of Oxford have reported findings from a Phase 2 clinical trial investigating the efficacy of an investigational treatment against long COVID fatigue.\r\n\r\nThe study (reported in Lancet eClinical Medicine) found participants given the treatment, developed by US pharmaceutical company Axcella Therapeutics, reported feeling less fatigued than those given a placebo.
\n \n\n\n \n 14 April 2023\n \n
\n\n \n \n \n\n \n \n \nThe University of Oxford-developed and Serum Institute of India PvT Ltd (SIIPL)- manufactured and scaled up R21/Matrix-MTM malaria vaccine, leveraging Novavax\u2019s adjuvant technology, has been licensed for use in Ghana by the country\u2019s Food and Drugs Authority.
\n \n\n\n \n 12 April 2023\n \n
\n\n \n \n \n\n \n \n \nThe University of Oxford is inviting schools and children to participate in a competition combining art and science.
\n \n\n\n \n 12 April 2023\n \n
\n\n \n \n \n\n \n \n \nA new Future Vaccines Manufacturing Hub aims to make the UK the global centre for discovering and manufacturing next-generation vaccines.
\n \n\n\n \n 12 April 2023\n \n
\n\n \n \n \n\n \n \n \nFour University of Oxford researchers have been awarded European Research Council (ERC) Advanced Grants of \u20ac2.5 million each over five years to explore their most innovative and ambitious ideas. These grants recognise ground-breaking projects led by researchers with a track record of significant research achievements.
\n \n\n